Woodworth Emily 4
Research Summary
AI-generated summary
Boston Scientific SVP Emily Woodworth Exercises Derivatives, Receives Awards
What Happened
Emily Woodworth, SVP, Global Controller and CAO of Boston Scientific (BSX), reported conversions/exercises of derivative awards and receipt of equity awards on Feb 12, 2026. The filing shows conversion/exercise entries for 481 derivative units and two awards/grants totaling 11,655 RSU-type units (6,071 and 5,584). To satisfy tax withholding, 242 shares were surrendered/disposed at $74.12 per share for $17,937. Exercise/conversion entries are recorded at $0.00 per share.
Key Details
- Transaction date: February 12, 2026; Form filed February 17, 2026 (appears timely based on provided data).
- Actions reported:
- Exercise/conversion of derivative: 481 shares (recorded $0.00).
- Tax withholding/payment: 242 shares disposed at $74.12 → $17,937.
- Additional exercise/conversion entry: 481 shares (recorded $0.00, listed as disposition of a derivative).
- Grants/awards: 6,071 and 5,584 shares reported as acquired (derivative/RSU treatment, $0.00).
- Shares owned after the transactions: Not specified in the provided filing excerpt.
- Relevant footnotes:
- F1: Each restricted stock unit (RSU) equals one share on issuance.
- F2: Includes ESPP shares acquired June 30, 2025 (most current data).
- F3/F4: Some awarded shares vest/are issued in four equal annual installments beginning Feb 12, 2025 (F3) and Feb 12, 2027 (F4).
- F5: Notes a grant of an option that vests in four equal annual installments beginning Feb 12, 2027.
- Transaction codes explanation: M = exercise/conversion of derivative; F = shares surrendered/withheld for tax liability; A = grant/award.
Context
- The filing indicates conversions/exercises and the typical tax withholding treatment (shares surrendered rather than cash payment). This is a routine insider equity administration action rather than an open-market purchase or sale intended to express market sentiment.
- Because the exercise/conversion is recorded at $0.00, it likely reflects conversion/vesting events (RSU settlement or similar) rather than a cash purchase; 242 shares were used to cover taxes.
- No 10% owner or 10b5-1 plan info is indicated in the provided excerpt.